company
Gopaldas Visram & Co., Ltd.
Industry: pharmaceutical
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_warning_letter · cgmp2026-06-02Gopaldas Visram & Co., Ltd. — CGMP/OTC Finished Pharmaceuticals/Adulterated (2026-06-02)
Frequently asked questions
- How many FDA warning letters has Gopaldas Visram & Co., Ltd. received?
- Argus HQ has recorded 1 FDA warning letter for Gopaldas Visram & Co., Ltd..
- What FDA recalls has Gopaldas Visram & Co., Ltd. issued?
- Argus HQ has not recorded an FDA recall tied to Gopaldas Visram & Co., Ltd. in our current dataset.
- Is Gopaldas Visram & Co., Ltd. FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Gopaldas Visram & Co., Ltd.. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

